IL10 and cancer: In particular, the p38 pathway served a negative regulatory role for IL-12 production in myDC in contrast to the canonical positive role in moDC.11–13 Interestingly, this was IL-12-specific, as p38 inhibition (p38i) reduced IL-10 (accepted to inhibit anti-cancer T cell responses) in both types of DC.